Cargando…

Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication

Post-SARS-CoV-2 telogen effluvium has been described in case reports of COVID-19 patients. We evaluated the prevalence of post-SARS-CoV-2 telogen effluvium in patients from a single medical center, exploring any causal links with the infection. Our hospital-based, cross-sectional study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Monari, Paola, Gualdi, Giulio, Bettoni, Giorgio, Costa, Raffaella, Ragni, Giorgio, Zani, Francesca, Bianchi, Giovanna, Casella, Silvia, Casella, Elisa, Crippa, Massimo, Calzavara Pinton, Piergiacomo, Di Nicola, Marta, Porreca, Annamaria, Amerio, Paolo, Guizzi, Pierangelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911426/
https://www.ncbi.nlm.nih.gov/pubmed/35268325
http://dx.doi.org/10.3390/jcm11051234
_version_ 1784666801560354816
author Monari, Paola
Gualdi, Giulio
Bettoni, Giorgio
Costa, Raffaella
Ragni, Giorgio
Zani, Francesca
Bianchi, Giovanna
Casella, Silvia
Casella, Elisa
Crippa, Massimo
Calzavara Pinton, Piergiacomo
Di Nicola, Marta
Porreca, Annamaria
Amerio, Paolo
Guizzi, Pierangelo
author_facet Monari, Paola
Gualdi, Giulio
Bettoni, Giorgio
Costa, Raffaella
Ragni, Giorgio
Zani, Francesca
Bianchi, Giovanna
Casella, Silvia
Casella, Elisa
Crippa, Massimo
Calzavara Pinton, Piergiacomo
Di Nicola, Marta
Porreca, Annamaria
Amerio, Paolo
Guizzi, Pierangelo
author_sort Monari, Paola
collection PubMed
description Post-SARS-CoV-2 telogen effluvium has been described in case reports of COVID-19 patients. We evaluated the prevalence of post-SARS-CoV-2 telogen effluvium in patients from a single medical center, exploring any causal links with the infection. Our hospital-based, cross-sectional study was conducted with patient participants discharged with a diagnosis of SARS-CoV-2 pneumonia from 1 March to 4 April 2020. All patients were evaluated by the same senior dermatologist; a clinical/dermatoscopic evaluation was performed. Alopecia was assessed in 31.3% of patients, with a significant difference in sex (females 73%, males 26.7%). The average time detected from the onset of the first symptoms to alopecia was 68.43 days. Overall, there were no significant associations between alopecia and COVID-19-related features (length of hospitalization, virologic positivity, or duration of fever), treatment characteristics, or laboratory findings. In this paper, we report that post-infection acute telogen effluvium occurs in a significant number of COVID-19 patients. The burden of this condition may impair the quality of life, with a significant impact on individuals.
format Online
Article
Text
id pubmed-8911426
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89114262022-03-11 Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication Monari, Paola Gualdi, Giulio Bettoni, Giorgio Costa, Raffaella Ragni, Giorgio Zani, Francesca Bianchi, Giovanna Casella, Silvia Casella, Elisa Crippa, Massimo Calzavara Pinton, Piergiacomo Di Nicola, Marta Porreca, Annamaria Amerio, Paolo Guizzi, Pierangelo J Clin Med Article Post-SARS-CoV-2 telogen effluvium has been described in case reports of COVID-19 patients. We evaluated the prevalence of post-SARS-CoV-2 telogen effluvium in patients from a single medical center, exploring any causal links with the infection. Our hospital-based, cross-sectional study was conducted with patient participants discharged with a diagnosis of SARS-CoV-2 pneumonia from 1 March to 4 April 2020. All patients were evaluated by the same senior dermatologist; a clinical/dermatoscopic evaluation was performed. Alopecia was assessed in 31.3% of patients, with a significant difference in sex (females 73%, males 26.7%). The average time detected from the onset of the first symptoms to alopecia was 68.43 days. Overall, there were no significant associations between alopecia and COVID-19-related features (length of hospitalization, virologic positivity, or duration of fever), treatment characteristics, or laboratory findings. In this paper, we report that post-infection acute telogen effluvium occurs in a significant number of COVID-19 patients. The burden of this condition may impair the quality of life, with a significant impact on individuals. MDPI 2022-02-24 /pmc/articles/PMC8911426/ /pubmed/35268325 http://dx.doi.org/10.3390/jcm11051234 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Monari, Paola
Gualdi, Giulio
Bettoni, Giorgio
Costa, Raffaella
Ragni, Giorgio
Zani, Francesca
Bianchi, Giovanna
Casella, Silvia
Casella, Elisa
Crippa, Massimo
Calzavara Pinton, Piergiacomo
Di Nicola, Marta
Porreca, Annamaria
Amerio, Paolo
Guizzi, Pierangelo
Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title_full Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title_fullStr Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title_full_unstemmed Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title_short Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
title_sort post-sars-cov-2 acute telogen effluvium: an expected complication
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911426/
https://www.ncbi.nlm.nih.gov/pubmed/35268325
http://dx.doi.org/10.3390/jcm11051234
work_keys_str_mv AT monaripaola postsarscov2acutetelogeneffluviumanexpectedcomplication
AT gualdigiulio postsarscov2acutetelogeneffluviumanexpectedcomplication
AT bettonigiorgio postsarscov2acutetelogeneffluviumanexpectedcomplication
AT costaraffaella postsarscov2acutetelogeneffluviumanexpectedcomplication
AT ragnigiorgio postsarscov2acutetelogeneffluviumanexpectedcomplication
AT zanifrancesca postsarscov2acutetelogeneffluviumanexpectedcomplication
AT bianchigiovanna postsarscov2acutetelogeneffluviumanexpectedcomplication
AT casellasilvia postsarscov2acutetelogeneffluviumanexpectedcomplication
AT casellaelisa postsarscov2acutetelogeneffluviumanexpectedcomplication
AT crippamassimo postsarscov2acutetelogeneffluviumanexpectedcomplication
AT calzavarapintonpiergiacomo postsarscov2acutetelogeneffluviumanexpectedcomplication
AT dinicolamarta postsarscov2acutetelogeneffluviumanexpectedcomplication
AT porrecaannamaria postsarscov2acutetelogeneffluviumanexpectedcomplication
AT ameriopaolo postsarscov2acutetelogeneffluviumanexpectedcomplication
AT guizzipierangelo postsarscov2acutetelogeneffluviumanexpectedcomplication